Ventum Cap Mkts upgraded shares of MariMed (OTCMKTS:MRMD – Free Report) to a strong-buy rating in a research report sent to investors on Thursday morning, Zacks.com reports.
MariMed Price Performance
Shares of MariMed stock remained flat at $0.18 on Thursday. The stock had a trading volume of 220,343 shares, compared to its average volume of 437,308. The firm has a market capitalization of $67.90 million, a price-to-earnings ratio of -4.47 and a beta of 2.80. The company has a current ratio of 1.55, a quick ratio of 0.73 and a debt-to-equity ratio of 1.01. The firm’s 50-day simple moving average is $0.18 and its 200-day simple moving average is $0.24. MariMed has a 12-month low of $0.14 and a 12-month high of $0.55.
About MariMed
Recommended Stories
- Five stocks we like better than MariMed
- Why Invest in 5G? How to Invest in 5G Stocks
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MarketBeat Week in Review – 8/5 – 8/9
- The Significance of Brokerage Rankings in Stock Selection
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.